Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-08-31
2008-03-04
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07338948
ABSTRACT:
A method of treating Attention Deficit Hyperactivity Disorder, Conduct Disorder and related disorders which comprises using the atypical antipychotic agent quetiapine.
REFERENCES:
patent: 5605897 (1997-02-01), Beasley et al.
patent: 5627178 (1997-05-01), Chakrabarti et al.
patent: 0240228 (1990-11-01), None
patent: 0240228 (1990-11-01), None
patent: WO 97/45124 (1997-12-01), None
Berkow, R., et al, The Merck Manual of Diagnosis and Therapy, 1992, Merck Research Laboratories, Sixteenth Edition, pp. 2102-2105, for example.
AstraZeneca AB
Cochran Karen
Hui San-Ming
Pepper Hamilton LLP
LandOfFree
Use of quetiapine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of quetiapine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of quetiapine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3971522